Published date: 10 May 2017

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 3 November 2016

Contract summary

Industry

  • Research and development consultancy services - 73200000

  • Market and economic research; polling and statistics - 79300000

Location of contract

London

Value of contract

£100,000

Procurement reference

UK SBS FWRECR16103BIS - Quantifying the factors which influence Life Science companies decisions to

Published date

10 May 2017

Closing date

3 November 2016

Contract start date

30 November 2016

Contract end date

28 February 2017

Contract type

Service contract

Procedure type

Other:

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

To inform policy and UKTIs inward investment activity we would like to understand and quantify the factors that influence the decisions to invest in a particular country at each stage of the R&D process and the factors which affect decisions on where to locate manufacturing facilities.
These factors may include, but are not necessarily limited to:
• local medicines spend (by both volume and price level, preferably by disease area);
• medicines uptake;
• concordant public R&D investment;
• capital availability;
• the tax environment;
• availability of government grants;
• skills availability;
• existing infrastructure;
• local Intellectual Property law and application;
• the regulatory environment; and
• access to local markets (NHS, EU), amongst others.
DH, BIS, OLS and wider government have a range of policies and priorities which may influence factors affecting Life Science company decisions on whether to invest in the UK. Understanding the factors that affect firms' investment decisions between countries will allow HMG to direct potential future policy interventions to ensure that they are well targeted, strategic, and offer good value for money. This will also inform OLS and UKTI LSO work attracting companies to locate in the UK.
A quantified understanding of the relationship between Life Science investment decisions and medicines uptake, pricing, and spend, may help inform NHS medicines spend.

Award information

Awarded date

14 November 2016

Contract start date

30 November 2016

Contract end date

28 February 2017

Total value of contract

£96,747.50

This contract was awarded to 1 supplier.

London Economics

Address

Somerset House New Wing
The Strand
London
WC2R 1LA

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Address

North Star House
North Star Avenue
Swindon
SN2 1FF
England

Email

Research@uksbs.co.uk